Portfolio company
DiNona
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops monoclonal antibody therapies and rapid diagnostic kits for medical researchers, healthcare providers and pharmaceutical organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Diana Biotechnologies
This company develops PCR diagnostic kits and molecular biology reagents for healthcare providers, pharmaceutical partners and academic laboratories.
DENCODA
This biotechnology company develops DNA-linked probes and diagnostic assays for researchers and healthcare providers to detect disease biomarkers and enzyme activities.
BioSpeedia
This company develops and produces rapid diagnostic kits for infectious diseases for health professionals and clinical diagnostic markets.
DxLab
This company develops point-of-care molecular testing systems and rapid diagnostic tests for pathogens to serve healthcare providers and public health teams.
Staten Biotechnology
This company develops monoclonal antibody therapies for patients with dyslipidaemia to reduce cardiovascular risk and lower triglyceride levels.
NOWDiagnostics
This company develops and manufactures rapid over-the-counter and point-of-care diagnostic tests for consumers and healthcare professionals.
Cognano
This company develops an artificial intelligence platform for antibody drug discovery and biomarker identification to support pharmaceutical firms and healthcare researchers.
